CUMBERLAND PHARMACEUTICALS INC - 8-K Filing
Cumberland Pharmaceuticals plans to submit a New Drug Application (NDA) for ifetroban as a treatment for Duchenne muscular dystrophy (DMD) cardiomyopathy.
Tickers: $CPIX
Cumberland Pharmaceuticals plans to submit a New Drug Application (NDA) for ifetroban as a treatment for Duchenne muscular dystrophy (DMD) cardiomyopathy.
Tickers: $CPIX